Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
CRVL
|
Corstar Holdings Inc |
SELL
Open market or private sale
|
Direct | 3,631 Reduced 0.05% |
$328,606
$90.5 p/Share
|
Oct 16
2020 |
FATE
|
Cindy Tahl
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 29,199 Reduced 22.68% |
$1,467,250
$50.25 p/Share
|
Oct 16
2020 |
EAF
|
Bcp Gp LTD |
SELL
Open market or private sale
|
Indirect | 137,000 Reduced 0.03% |
$994,620
$7.26 p/Share
|
Oct 16
2020 |
EAF
|
Bcp Gp LTD |
SELL
Open market or private sale
|
Indirect | 137,000 Reduced 0.03% |
$994,620
$7.26 p/Share
|
Oct 16
2020 |
TLRY
|
Brendan Kennedy
Director |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 3.61% |
$2,240,000
$5.6 p/Share
|
Oct 16
2020 |
FSLY
|
Joshua Bixby
CEO |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 3.19% |
$871,800
$87.18 p/Share
|
Oct 16
2020 |
KALU
|
Keith Harvey
President & CEO |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.67% |
$32,500
$65.0 p/Share
|
Oct 16
2020 |
XPEL
|
Mark Adams
Director |
SELL
Open market or private sale
|
Direct | 7,741 Reduced 0.26% |
$210,091
$27.14 p/Share
|
Oct 16
2020 |
ADPT
|
Harlan S Robins
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 11,100 Reduced 94.24% |
$574,869
$51.79 p/Share
|
Oct 16
2020 |
LZB
|
Kurt L Darrow
Director |
SELL
Open market or private sale
|
Direct | 42,613 Reduced 6.89% |
$1,496,142
$35.11 p/Share
|
Oct 16
2020 |
SCSC
|
Michael L Baur
CEO & Chairman of the Board |
SELL
Open market or private sale
|
Direct | 1,069 Reduced 1.63% |
$23,593
$22.07 p/Share
|
Oct 16
2020 |
IDT
|
Joyce J Mason
EVP and Corporate Secretary |
SELL
Open market or private sale
|
Direct | 2,701 Reduced 7.49% |
$28,901
$10.7 p/Share
|
Oct 16
2020 |
IDT
|
Joyce J Mason
EVP and Corporate Secretary |
SELL
Open market or private sale
|
Indirect | 4,282 Reduced 27.96% |
$46,288
$10.81 p/Share
|
Oct 16
2020 |
FLWS
|
Christopher G Mccann
Director |
SELL
Open market or private sale
|
Direct | 27,724 Reduced 2.46% |
$805,659
$29.06 p/Share
|
Oct 16
2020 |
QTRX
|
David C. Duffy
SVP R&D and CTO |
SELL
Open market or private sale
|
Direct | 1,667 Reduced 3.75% |
$71,748
$43.04 p/Share
|
Oct 16
2020 |
STOK
|
Gene Liau
EVP Research & Preclinical Dev |
SELL
Open market or private sale
|
Direct | 5,851 Reduced 30.24% |
$234,040
$40.0 p/Share
|
Oct 16
2020 |
UPLD
|
Timothy Mattox
Director |
SELL
Open market or private sale
|
Direct | 7,232 Reduced 1.38% |
$325,440
$45.0 p/Share
|
Oct 16
2020 |
SIBN
|
Jeffrey W Dunn |
SELL
Open market or private sale
|
Direct | 1,818 Reduced 0.79% |
$42,778
$23.53 p/Share
|
Oct 16
2020 |
SIBN
|
Anthony J Recupero
President, Commercial Ops |
SELL
Open market or private sale
|
Direct | 587 Reduced 0.83% |
$13,812
$23.53 p/Share
|
Oct 16
2020 |
SIBN
|
Michael A Pisetsky
SVP, Ops & Adm/Chief Legal Ofr |
SELL
Open market or private sale
|
Direct | 247 Reduced 0.5% |
$5,812
$23.53 p/Share
|
Oct 16
2020 |
WKHS
|
Stephen M. Fleming
Vice President |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 9.43% |
$1,150,000
$23.0 p/Share
|
Oct 16
2020 |
WKHS
|
Anthony Daly Furey
Vice President-Finance |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 16.76% |
$1,150,000
$23.0 p/Share
|
Oct 16
2020 |
WKHS
|
Duane Hughes
CEO and President |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 12.87% |
$1,150,000
$23.0 p/Share
|
Oct 16
2020 |
PNTG
|
Daniel H Walker
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 2,247 Reduced 0.34% |
$90,105
$40.1 p/Share
|
Oct 16
2020 |
PRTS
|
Joshua L Berman
Director |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 16.74% |
$250,800
$12.54 p/Share
|
Oct 16
2020 |
KALV
|
Christopher Yea
CHIEF DEVELOPMENT OFFICER |
SELL
Open market or private sale
|
Direct | 914 Reduced 1.1% |
$15,538
$17.0 p/Share
|
Oct 16
2020 |
KALV
|
Edward P. Feener
CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct | 993 Reduced 1.03% |
$16,881
$17.0 p/Share
|
Oct 16
2020 |
GNLN
|
Aaron Lo Cascio
Director |
SELL
Open market or private sale
|
Direct | 20,679 Reduced 14.04% |
$60,176
$2.91 p/Share
|
Oct 16
2020 |
FTLF
|
Lewis Jaffe |
SELL
Open market or private sale
|
Direct | 14,431 Reduced 100.0% |
$194,818
$13.5 p/Share
|
Oct 16
2020 |
LOVE
|
Andrew R Heyer
Director |
SELL
Open market or private sale
|
Indirect | 149,396 Reduced 0.73% |
$5,343,895
$35.77 p/Share
|
Oct 16
2020 |
EIGI
|
Barry Christine Timmins
COO, Web Presence |
SELL
Open market or private sale
|
Direct | 6,847 Reduced 1.28% |
$40,055
$5.85 p/Share
|
Oct 16
2020 |
DRNA
|
Bob D Brown
Chief Scientific Ofr., EVP R&D |
SELL
Open market or private sale
|
Direct | 16,370 Reduced 38.17% |
$343,770
$21.0 p/Share
|
Oct 16
2020 |
LEGH
|
Curtis Drew Hodgson
Director |
SELL
Open market or private sale
|
Indirect | 288 Reduced 0.01% |
$4,421
$15.35 p/Share
|
Oct 16
2020 |
BHVN
|
Gregory Bailey |
SELL
Open market or private sale
|
Direct | 3,748 Reduced 0.14% |
$295,642
$78.88 p/Share
|
Oct 16
2020 |
GSHD
|
Mark Evan Jones
Executive Chairman |
SELL
Open market or private sale
|
Indirect | 21,211 Reduced 44.31% |
$2,244,760
$105.83 p/Share
|
Oct 16
2020 |
GSHD
|
Robyn Mary Elizabeth Jones
Director |
SELL
Open market or private sale
|
Indirect | 21,211 Reduced 44.31% |
$2,244,760
$105.83 p/Share
|
Oct 16
2020 |
GSHD
|
Mark & Robyn Jones Descendants Trust 2014
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 21,211 Reduced 100.0% |
$2,244,760
$105.83 p/Share
|
Oct 16
2020 |
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 5,000 Reduced 0.02% |
$1,000
$0.2 p/Share
|
Oct 16
2020 |
VPLM
|
Dennis Chang
SECRETARY |
SELL
Open market or private sale
|
Direct | 400,000 Reduced 1.26% |
$8,000
$0.02 p/Share
|
Oct 16
2020 |
VPLM
|
Barbara Baggio |
SELL
Open market or private sale
|
Direct | 626,570 Reduced 1.16% |
$12,531
$0.02 p/Share
|
Oct 15
2020 |
EAF
|
Bcp Gp LTD |
SELL
Open market or private sale
|
Indirect | 137,000 Reduced 0.03% |
$991,880
$7.24 p/Share
|
Oct 15
2020 |
ADN
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.61% |
$103,500
$10.35 p/Share
|
Oct 15
2020 |
RNG
|
Vladimir Shmunis
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 5.04% |
$2,721,500
$272.15 p/Share
|
Oct 15
2020 |
PFSI
|
Stanford L Kurland
Director |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.01% |
$66,520
$66.52 p/Share
|
Oct 15
2020 |
CRVL
|
V Gordon Clemons
Chairman of the Board |
SELL
Open market or private sale
|
Indirect | 1,000 Reduced 0.15% |
$88,380
$88.38 p/Share
|
Oct 15
2020 |
CRVL
|
Corstar Holdings Inc |
SELL
Open market or private sale
|
Direct | 3,353 Reduced 0.05% |
$301,535
$89.93 p/Share
|
Oct 15
2020 |
SDGR
|
David E Shaw
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 156,466 Reduced 0.58% |
$8,760,532
$55.99 p/Share
|
Oct 15
2020 |
EAF
|
Bcp Gp LTD |
SELL
Open market or private sale
|
Indirect | 137,000 Reduced 0.03% |
$991,880
$7.24 p/Share
|
Oct 15
2020 |
EAF
|
Bcp Gp LTD |
SELL
Open market or private sale
|
Indirect | 137,000 Reduced 0.03% |
$991,880
$7.24 p/Share
|
Oct 15
2020 |
RVMD
|
Elizabeth M Anderson |
SELL
Open market or private sale
|
Indirect | 4,780 Reduced 15.05% |
$215,100
$45.0 p/Share
|
Oct 15
2020 |